International Rare Cancers Initiative Multicenter Randomized Phase II Trial of Cisplatin and Fluorouracil Versus Carboplatin and Paclitaxel in Advanced Anal Cancer: InterAAct | Zendy

Sheela Rao | Zendy; Francesco Sclafani | Zendy; Cathy Eng | Zendy; Richard Adams | Zendy; Marianne G. Guren | Zendy; David SebagMontefiore | Zendy; Al B. Benson | Zendy; Annette Bryant | Zendy; Clare Peckitt | Zendy; Eva Segelov | Zendy; Amitesh Roy | Zendy; Michel Seymour | Zendy; Jack Welch | Zendy; Mark Saunders | Zendy; R. Muirhead | Zendy; Peter J. O’Dwyer | Zendy; John Bridgewater | Zendy; Shree Bhide | Zendy; R. GlynneJones | Zendy; Dirk Arnold | Zendy; David Cunningham | Zendy

Open Access

International Rare Cancers Initiative Multicenter Randomized Phase II Trial of Cisplatin and Fluorouracil Versus Carboplatin and Paclitaxel in Advanced Anal Cancer: InterAAct

Author(s) -

Sheela Rao,

Francesco Sclafani,

Cathy Eng,

Richard Adams,

Marianne G. Guren,

David SebagMontefiore,

Al B. Benson,

Annette Bryant,

Clare Peckitt,

Eva Segelov,

Amitesh Roy,

Michel Seymour,

Jack Welch,

Mark Saunders,

R. Muirhead,

Peter J. O’Dwyer,

John Bridgewater,

Shree Bhide,

R. GlynneJones,

Dirk Arnold,

David Cunningham

Publication year - 2020

Publication title -

journal of clinical oncology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 10.482

H-Index - 548

eISSN - 1527-7755

pISSN - 0732-183X

DOI - 10.1200/jco.19.03266

Subject(s) - carboplatin , medicine , cisplatin , regimen , paclitaxel , clinical endpoint , chemotherapy , fluorouracil , phases of clinical research , multicenter trial , urology , surgery , oncology , gastroenterology , randomized controlled trial , multicenter study

To compare cisplatin plus fluorouracil (FU) versus carboplatin plus paclitaxel in chemotherapy-naïve advanced anal cancer to establish the optimal regimen.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research